Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ruiying Pharmaceutical Group is a Chinese pharmaceutical manufacturing company based in Heze, Shandong, focused on active pharmaceutical ingredients, intermediates, sterile APIs, and finished dosage products. The company operates across biological fermentation, chemical synthesis, and aseptic pharmaceutical manufacturing, and it also markets contract development and manufacturing services. Public profiles describe a portfolio of more than 100 intermediates, over 50 APIs, and more than 100 preparations, with particular historical emphasis on cephalosporins, penicillins, and antineoplastic products. Ruiying appears to be a commercially operating manufacturer rather than a venture-stage biotech, with international certifications and export activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ruiying Pharmaceutical Group.